These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24907154)

  • 1. Endothelial function in patients with familial Mediterranean fever-related amyloidosis and association with cardiovascular events.
    Yilmaz MI; Demirkaya E; Acikel C; Saldir M; Akar S; Cayci T; Saglam M; Unal HU; Gok M; Polat A; Cetinkaya H; Eyileten T; Sari S; Yildirim AO; Sonmez A; Oguz Y; Vural A; Ozen S; Carrero JJ
    Rheumatology (Oxford); 2014 Nov; 53(11):2002-8. PubMed ID: 24907154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of endothelial dysfunction in patients with familial Mediterranean fever: the relationship between the levels of asymmetric dimethylarginine and endocan with carotid intima-media thickness and endothelium-dependent vasodilation.
    Ozalper V; Kara M; Tanoglu A; Cetındaglı I; Ozturker C; Hancerlı Y; Hıra S; Kara K; Beyazıt Y; Yazgan Y
    Clin Rheumatol; 2017 Sep; 36(9):2071-2077. PubMed ID: 28074304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased asymmetric dimethylarginine levels in young men with familial Mediterranean fever (FMF): is it early evidence of interaction between inflammation and endothelial dysfunction in FMF?
    Terekeci HM; Oktenli C; Ozgurtas T; Nalbant S; Top C; Celik S; Tapan S; Kucukardali Y; Sanisoglu YS; Solmazgul E; Sahan B; Sayan O
    J Rheumatol; 2008 Oct; 35(10):2024-9. PubMed ID: 18785307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esophageal motor function in Familial Mediterranean Fever: a prospective evaluation of motility in 31 patients.
    Bektaş M; Doğanay B; Alkan M; Ustun Y; Soykan I
    Eur J Intern Med; 2009 Sep; 20(5):548-50. PubMed ID: 19712864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular disease risk assessment in patients with familial Mediterranean fever related renal amyloidosis.
    Romano M; Piskin D; Berard RA; Jackson BC; Acikel C; Carrero JJ; Lachmann HJ; Yilmaz MI; Demirkaya E
    Sci Rep; 2020 Oct; 10(1):18374. PubMed ID: 33110219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADMA levels correlate with proteinuria, secondary amyloidosis, and endothelial dysfunction.
    Yilmaz MI; Sonmez A; Saglam M; Qureshi AR; Carrero JJ; Caglar K; Eyileten T; Cakir E; Oguz Y; Vural A; Yenicesu M; Lindholm B; Stenvinkel P; Axelsson J
    J Am Soc Nephrol; 2008 Feb; 19(2):388-95. PubMed ID: 18199801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial Mediterranean fever (FMF) with proteinuria: clinical features, histology, predictors, and prognosis in a cohort of 25 patients.
    Kukuy O; Livneh A; Ben-David A; Kopolovic J; Volkov A; Shinar Y; Holtzman E; Dinour D; Ben-Zvi I
    J Rheumatol; 2013 Dec; 40(12):2083-7. PubMed ID: 24128782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
    Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
    Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is colchicine therapy effective in all patients with secondary amyloidosis?
    Unverdi S; Inal S; Ceri M; Unverdi H; Batgi H; Tuna R; Ozturk MA; Guz G; Duranay M
    Ren Fail; 2013 Sep; 35(8):1071-4. PubMed ID: 23841746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADMA is independently related to flow-mediated vasodilation in subjects at low cardiovascular risk.
    Ardigo D; Stüehlinger M; Franzini L; Valtueña S; Piatti PM; Pachinger O; Reaven GM; Zavaroni I
    Eur J Clin Invest; 2007 Apr; 37(4):263-9. PubMed ID: 17373961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QT variability in amyloidosis of familial Mediterranean fever.
    Nussinovitch U; Ben-Zvi I; Livneh A
    Isr Med Assoc J; 2012 Apr; 14(4):225-8. PubMed ID: 22675838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AA type renal amyloidosis secondary to FMF: a long-term follow-up in two patients.
    Aybal Kutlugün A; Yildirim T; Altindal M; Arici M; Yasavul U; Turgan C
    Ren Fail; 2010; 32(10):1230-2. PubMed ID: 20954987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Inflammatory, Antioxidant, and Anti-Atherosclerotic Effects of Natural Supplements on Patients with FMF-Related AA Amyloidosis: A Non-Randomized 24-Week Open-Label Interventional Study.
    Romano M; Garcia-Bournissen F; Piskin D; Rodoplu U; Piskin L; Elzagallaai AA; Tuncer T; Sezer S; Ucuncuoglu D; Honca T; Poddighe D; Yavuz I; Stenvinkel P; Yilmaz MI; Demirkaya E
    Life (Basel); 2022 Jun; 12(6):. PubMed ID: 35743929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of dialytic modalities on clinical outcomes in ESRD patients with familial Mediterranean fever.
    Sahin S; Sahin GM; Ergin H; Kantarci G
    Ren Fail; 2007; 29(3):315-9. PubMed ID: 17497446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased soluble FAS suggests delayed apoptosis in familial Mediterranean fever complicated with amyloidosis.
    Kiraz S; Ertenli I; Oztürk MA; Haznedaroglu IC; Calgüneri M; Atalar E; Ozbalkan Z; Kirazli S; Celik I
    J Rheumatol; 2003 Feb; 30(2):313-5. PubMed ID: 12563687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Familial Mediterranean Fever (FMF): from diagnosis to treatment].
    Medlej-Hashim M; Loiselet J; Lefranc G; Mégarbané A
    Sante; 2004; 14(4):261-6. PubMed ID: 15745878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tubular functions in familial Mediterranean fever.
    Akkuş S; Calişkan S; Kasapçopur O
    Turk J Pediatr; 2002; 44(4):317-20. PubMed ID: 12458807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the hypercoagulable state by measuring protein C and antithrombin III levels in nephrotic syndrome and in familial Mediterranean fever-related amyloidosis.
    Topaloğlu R; Saatçi U; Bakkaloğlu A; Beşbaş N; Başsoy Y
    Turk J Pediatr; 1992; 34(1):15-20. PubMed ID: 1509525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome.
    Moran LJ; Hutchison SK; Meyer C; Zoungas S; Teede HJ
    Clin Sci (Lond); 2009 May; 116(10):761-70. PubMed ID: 18851710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary glycosaminoglycan levels as a marker of renal amyloidosis in patients with familial Mediterranean fever.
    Nadir H; Unver S; Ozel AM; Yazgan Y; Gultepe M; Evrenkaya TR; Demirturk L; Gurbuz AK
    Ren Fail; 2007; 29(1):73-7. PubMed ID: 17365913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.